Isolated Familial Plasminogen Deficiency May not Be a Risk Factor for Thrombosis

Summary

Despite many reports of individuals with congenital plasminogen deficiency and thrombosis, there is still uncertainty whether heterozygous deficiency represents a real thrombophilic risk factor or simply a coincidental finding. We have addressed this issue by testing for plasminogen deficiency in a cohort of 9611 blood donors. Out of 66 donors with reduced plasminogen activity on two occasions 28 were shown to have a familial deficiency state (including 3 with dysplasminogen-aemia). Our observed prevalence rate for familial plasminogen deficiency, calculated at 2.9/1000 (95% Cl = 1.9-4.2 per 1000), was not significantly different from that calculated from published reports of congenital plasminogen deficiency in thrombotic cohorts (5.4/1000). Furthermore, with only two exceptions, all 80 donors and relatives with familial deficiency were asymptomatic with regard to thrombosis -including a 29 year old donor with suspected compound heterozygous hypoplasminogenaemia. These findings add further weight to the argument that familial heterozygous plasminogen deficiency, at least in isolation, does not constitute a significant thrombotic risk factor. However, it remains uncertain whether plasminogen deficiency, when combined with other thrombophilic conditions, may become more clinically important.

• References

• 1 Kluft C, Verheijen JH, Engesser L. Fibrinolysis and thrombophilia; an introduction. Fibrinolysis 1988; 2 (Suppl. 02) 1-6
• 2 Bertina RM. Prevalence of hereditary thrombophilia and the identification of genetic risk factors. Fibrinolysis 1988; 2 (Suppl. 02) 7-13
• 3 Lijnen HR, Collen D. Congenital and acquired deficiences of components of the fibrinolytic system and their relation to bleeding or thrombosis. Fibrinolysis 1989; 3: 67-77
• 4 Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J 1985; 290: 1453-1455
• 5 Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboembolic disease - critical evaluation of laboratory investigations. Thromb Haemost 1992; 68: 7-13
• 6 Petaja J, Rasi V, Myllyla G, Hallman V, Hallman H. Familial hypofibrinolysis and venous thrombosis. Br J Haematol 1989; 71: 393-398
• 7 Engesser L, Brommer EJP, Kluft C, Briet E. Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? - A study in 203 patients with familial or sporadic venous thrombophilia. Thromb Haemost 1989; 62: 673-680
• 8 Patrassi GM, Sartori MT, Saggiorato G, Boeri G, Girolami A. Familial thrombophilia associated with high levels of plasminogen activator inhibitor. Fibrinolysis 1992; 6: 99-103
• 9 Kluft C, Leebeek FWG. Alpha-2-antiplasmin and thrombosis: Results of a questionnaire. Fibrinolysis 1988; 2 (Suppl. 02) 47-48
• 10 Ehrenforth S, Aygoren-Pursun E, Hach-Wunderle V, Scharrer I. Prevalence of elevated histidine-rich glycoprotein in patients with thrombophilia - a study of 695 patients. Thromb Haemost 1994; 71: 160-161
• 11 Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal Plasminogen. J Clin Invest 1978; 61: 1186-1195
• 12 Hasegawa DK, Tyler BJ, Edson JR. Thrombotic disease in three families with inherited plasminogen deficiency. Blood 1982; 60 (Suppl. 01) 213a
• 13 Kazama M, Tahara C, Suzuki Z, Gohchi K, Abe T. Abnormal Plasminogen, a case of recurrent thrombosis. Thromb Res 1981; 21: 517-522
• 14 Soria J, Soria C, Bertrand O, Dunn F, Drouet L, Caen JP. Plasminogen Paris I: Congenital abnormal plasminogen and its incidence in thrombosis. Thromb Res 1983; 32: 229-238
• 15 Robbins KC. Classification of abnormal plasminogens: dysplasminogenemias. Semin Thromb Hemost 1990; 16: 217-220
• 16 Dolan G, Greaves M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol 1988; 70: 417-421
• 17 Tabemero MD, Sarmiento RG, Tomas JF, Alberca I. Plasminogen deficiency in a Spanish family. Fibrinolysis 1988; 2 (Suppl. 02) 40-42
• 18 Scharrer I, Hach-Wunderle V, Wohl RC, Sinio L, Boreisha I, Robbins KC. Congenital abnormal plasminogen, Frankfurt I, a cause for recurrent venous thrombosis. Haemostasis 1988; 18: 77-86
• 19 Girolami A, Marafioti F, Rubertelli M, Cappellato MG. Congenital heterozygous plasminogen deficiency associated with sever thrombotic tendency. Acta Haematol 1986; 75: 54-57
• 20 Mannucci PM, Kluft C, Traas W, Seveso P, D’Angelo A. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol. Br J Haematol 1986; 63: 753-759
• 21 Dolan G, Preston FE. Familial plasminogen deficiency and thromboembolism. Fibrinolysis 1988; 2 (Suppl. 02) 26-34
• 22 Sartori MT, Patrassi GM, Theodoridis P, Perin A, Pietrogrande F, Girolami A. Heterozygous type I plasminogen deficiency is associated with increased risk for thrombosis: a stastical analysis in 20 kindreds. Blood Coag Fibrinol 1994; 5: 889-893
• 23 Girolami A, Sartori MT, Sgarabotto D, Patrassi GM. Spontaneous versus secondary thrombosis in congenital heterozygous plasminogen deficiency. Thromb Haemost 1993; 69: 530-531
• 24 Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 1992; 67: 189-192
• 25 Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and Factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995; 74: 449-453
• 26 Tait RC, Walker ID, Reitsma PH, Islam SIAM, McCall F, Poort SR, Conkie JA, Bertina RM. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73: 87-93
• 27 Tait RC, Walker ID, Perry DJ, Islam SIAM, Daly ME, McCall F, Conkie JA, Carrell RW. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-112
• 28 Tait RC, Walker ID, Conkie JA, Islam SIAM, McCall F, Mitchell R, Davidson JF. Plasminogen levels in healthy volunteers - influence of age, sex, smoking and oral contraceptives. Thromb Haemost 1992; 68: 506-510
• 29 Peterson RA, Krull PE, Finley P, Ettinger MG. Changes in antithrombin III and plasminogen induced by oral contraceptives. Am J Clin Pathol 1970; 53: 468-473
• 30 Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-138
• 31 Finazzi G, Caccia R, Barbui T. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: Review of 404 cases. Thromb Haemost 1987; 58: 1094
• 32 Jespersen J, Kluft C. Decreased levels of histidine-rich glycoprotein (HRG) and increased levels of free plasminogen in women on oral contraceptives low in estrogen. Thromb Haemost 1982; 48: 283-285
• 33 Aoki N, Tateno K, Sakata Y. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: New methods for detection of plasminogen variants. Biochem Genet 1984; 22: 871-881
• 34 Kazama M, Tahara C, Naito I, Nakamura K, Matsuda J, Abe T. Incidence of congenital abnormality of plasminogen in healthy adults and in severe disease. Thromb Haemost 1983; 50: 258a
• 35 Engesser L, Briet E, Dubbeldam J, Kret MJ, Brommer EJP. Disorders of coagulation and fibrinolysis and their association with venous thrombophilia: A study in 203 unrelated patients. In: Thrombophilia - Disorders of blood coagulation and fibrinolysis Engesser L. ed Krips Repro Meppel; 1988: 91-128
• 36 Briet E, Engesser L, Brommer EJP, Broekmans AW, Bertina RM. Thrombophilia: Its causes and a rough estimate of its prevalence. Thromb Haemost 1987; 58: 39a
• 37 Melissari E, Monte G, Lindo VS, Pemberton KD, Wilson NV, Edmondson R, Das S, Kakkar VV. Congenital thrombophilia among patients with venous thromboembolism. Blood Coag Fibrinol 1992; 3: 749-758
• 38 Scharrer I, Hach-Wunderle V, Aygoren E, Lottenberg R, Robbins KC. Frequency and clinical manifestations of congenital plasminogen and fibrinogen deficiency compared to AT III-, PC-, and PS- deficiency in patients suffering from thromboses. Fibrinolysis 1988; 2 (Suppl. 02) 16-17
• 39 Tabemero MD, Thomas JF, Alberca I, Orfao A, Borrasca AL, Vicente V. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Haematol 1991; 36: 249-254